Galapagos NV
GLPG
#4563
Rank
A$3.17 B
Marketcap
A$47.56
Share price
-0.57%
Change (1 day)
13.82%
Change (1 year)

Galapagos NV (GLPG) - Net assets

Net assets on the balance sheet as of September 2025 : A$4.32 Billion

According to Galapagos NV's latest financial reports the company has A$4.32 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Galapagos NV - Net assets on balance sheet (from 2008 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$A$4.84 B6.85%
2023-12-31$A$4.53 B13.92%
2022-12-31$A$3.98 B-3.57%
2021-12-31$A$4.12 B-3.33%
2020-12-31$A$4.27 B-7.16%
2019-12-31$A$4.60 B133.34%
2018-12-31$A$1.97 B26.78%
2017-12-31$A$1.55 B40.48%
2016-12-31$A$1.10 B102.09%
2015-12-31$A$0.54 B78.83%
2014-12-31$A$0.30 B18.38%
2013-12-31$A$0.25 B71.63%
2012-12-31$A$0.15 B0.56%
2011-12-31$A$0.14 B-22.9%
2010-12-31$A$0.19 B11.99%
2009-12-31$A$0.17 B3.92%
2008-12-31$A$0.16 B1.44%
2007-12-31$A$0.16 B-10.17%
2006-12-31$A$0.18 B85.25%
2005-12-31$A$98.97 M444.65%
2004-12-31$A$18.17 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
AstraZeneca
AZN
A$69.20 B 1,500.82%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
A$119.35 B 2,660.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$129.92 B 2,905.07%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
-A$3.92 Billion-190.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
A$56.28 M-98.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$77.17 B 1,685.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$10.92 B 152.60%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
A$31.88 B 637.40%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
A$78.14 B 1,707.52%๐Ÿ‡บ๐Ÿ‡ธ USA